{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"efinopegdutide","name":"Efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":10,"objects":{"clinicaltrials-gov-nct03235219-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03235219-efinopegdutide:v1","objectPathId":"clinicaltrials-gov-nct03235219-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03235219-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#clinicaltrials-gov-nct03235219-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#clinicaltrials-gov-nct03235219-efinopegdutide-v1"},"story":{"slug":"clinicaltrials-gov-nct03235219-efinopegdutide","version":1,"domain":"Clinical trials","dateInSource":"2025-04-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03235219","sourceIds":["ctg-observation-nct03235219-2025-04-27-03acbc41c1c9"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03235219 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-04-27, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct03235219-2025-04-27-03acbc41c1c9"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03235219 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-04-27, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct03235219-2025-04-27-03acbc41c1c9"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03235219-2025-04-27-03acbc41c1c9"]}],"sources":[{"id":"ctg-observation-nct03235219-2025-04-27-03acbc41c1c9","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03235219 · retained source version 2025-04-27:03acbc41c1c9d51180ff3e7d8137238bfc0f269ef3f35b44045f526fc7db631e","url":"https://clinicaltrials.gov/study/NCT03235219"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0dd14e32f63e2b89d4a4edc042a3b4260259abfa85f5d1c616d0df496d4b723c","tierARecordSha256":"06d6920ab6b3cd46d93cb42e0ef5194bd820dda1d052254e0ecfbe7568a7449b"},"integrity":{"algorithm":"sha256","contentSha256":"e0a7f569e39ec9f9b2e4c2b2f1f6e02c1c945005f2b269147ca4e9eb3e357346"}},"clinicaltrials-gov-nct03546205-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03546205-efinopegdutide:v1","objectPathId":"clinicaltrials-gov-nct03546205-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03546205-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#clinicaltrials-gov-nct03546205-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#clinicaltrials-gov-nct03546205-efinopegdutide-v1"},"story":{"slug":"clinicaltrials-gov-nct03546205-efinopegdutide","version":1,"domain":"Clinical trials","dateInSource":"2025-04-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03546205","sourceIds":["ctg-observation-nct03546205-2025-04-27-94976add2223"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03546205 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-04-27, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct03546205-2025-04-27-94976add2223"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03546205 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-04-27, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct03546205-2025-04-27-94976add2223"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03546205-2025-04-27-94976add2223"]}],"sources":[{"id":"ctg-observation-nct03546205-2025-04-27-94976add2223","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03546205 · retained source version 2025-04-27:94976add22232980b361e6a6dc6fc3350a7eee86d13d376ffa5e395f534f97ed","url":"https://clinicaltrials.gov/study/NCT03546205"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"88e1ca24427404da65204823ae13cb7c3fc948cd9cca7303368fc01664baa1ca","tierARecordSha256":"28434a7e241d7a3a7ac7788d069850f37db822b2d349b77db5eddd60c7c5b5fe"},"integrity":{"algorithm":"sha256","contentSha256":"700abf9c2d73db48d0f534fe0947af5e59844453622fe06dd8a934ddfe259b75"}},"clinicaltrials-gov-nct03586843-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03586843-efinopegdutide:v1","objectPathId":"clinicaltrials-gov-nct03586843-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03586843-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#clinicaltrials-gov-nct03586843-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#clinicaltrials-gov-nct03586843-efinopegdutide-v1"},"story":{"slug":"clinicaltrials-gov-nct03586843-efinopegdutide","version":1,"domain":"Clinical trials","dateInSource":"2019-04-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03586843","sourceIds":["ctg-observation-nct03586843-2019-04-16-de87c576d57a"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03586843 at 2026-11-16T17:46:45.897Z. Its registry update date was 2019-04-16, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct03586843-2019-04-16-de87c576d57a"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03586843 at 2026-11-16T17:46:45.897Z. Its registry update date was 2019-04-16, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct03586843-2019-04-16-de87c576d57a"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03586843-2019-04-16-de87c576d57a"]}],"sources":[{"id":"ctg-observation-nct03586843-2019-04-16-de87c576d57a","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03586843 · retained source version 2019-04-16:de87c576d57ad04eee3a86b46ef97dd247a6698460bbc1e6fce8b9086de758ff","url":"https://clinicaltrials.gov/study/NCT03586843"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ca3d254dbaceee20ded79992ef1d2c79d8dcbe4594cce1c9513ca885a114f14f","tierARecordSha256":"0eacc35c13c22be1be56e5f1e94380da7583917cb48c6d823942616ed90a5e49"},"integrity":{"algorithm":"sha256","contentSha256":"82f9cdaa273cc2984e61da698f49f4da35adb6777950aba8f57748efa637313e"}},"clinicaltrials-gov-nct03606057-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03606057-efinopegdutide:v1","objectPathId":"clinicaltrials-gov-nct03606057-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03606057-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#clinicaltrials-gov-nct03606057-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#clinicaltrials-gov-nct03606057-efinopegdutide-v1"},"story":{"slug":"clinicaltrials-gov-nct03606057-efinopegdutide","version":1,"domain":"Clinical trials","dateInSource":"2020-03-03","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03606057","sourceIds":["ctg-observation-nct03606057-2020-03-03-c5f32867e4ce"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03606057 at 2026-11-16T17:46:45.897Z. Its registry update date was 2020-03-03, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct03606057-2020-03-03-c5f32867e4ce"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03606057 at 2026-11-16T17:46:45.897Z. Its registry update date was 2020-03-03, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct03606057-2020-03-03-c5f32867e4ce"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03606057-2020-03-03-c5f32867e4ce"]}],"sources":[{"id":"ctg-observation-nct03606057-2020-03-03-c5f32867e4ce","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03606057 · retained source version 2020-03-03:c5f32867e4ce2032a7fa655528b08a223095493434817f1d73a5dd11b16e8dac","url":"https://clinicaltrials.gov/study/NCT03606057"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"63c5d1244489a07dc2265dfb6120ea8c8d5dddab4988b62622a579d6b370d3fc","tierARecordSha256":"dd76f0a8b3f89da183c307872a2a610414b875ab00564b524f56adc4e35f1709"},"integrity":{"algorithm":"sha256","contentSha256":"9415dc92418f8e42af397a2f878ecce30b514caac72d006252dec79a08cfbf25"}},"clinicaltrials-gov-nct06052566-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06052566-efinopegdutide:v1","objectPathId":"clinicaltrials-gov-nct06052566-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06052566-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#clinicaltrials-gov-nct06052566-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#clinicaltrials-gov-nct06052566-efinopegdutide-v1"},"story":{"slug":"clinicaltrials-gov-nct06052566-efinopegdutide","version":1,"domain":"Clinical trials","dateInSource":"2025-10-22","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06052566","sourceIds":["ctg-observation-nct06052566-2025-10-22-b1554b8fd592"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06052566 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-10-22, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06052566-2025-10-22-b1554b8fd592"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06052566 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-10-22, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06052566-2025-10-22-b1554b8fd592"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06052566-2025-10-22-b1554b8fd592"]}],"sources":[{"id":"ctg-observation-nct06052566-2025-10-22-b1554b8fd592","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06052566 · retained source version 2025-10-22:b1554b8fd592b3c55c53adef0787f1e2478f12aab16ccffcf92f4f82a3d64bd5","url":"https://clinicaltrials.gov/study/NCT06052566"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"78722f091909482c9f1957ed944c01108b6fbda143b8e409d09cc03a4102e4e1","tierARecordSha256":"fa81dae097e280371a2b6e79f30346f5581370a6fd131c9d28d0e46566a02543"},"integrity":{"algorithm":"sha256","contentSha256":"011aa24483e4c7de12b2d18ba2d8d474580f83bfbb0298be476438946cfd3027"}},"clinicaltrials-gov-nct06465186-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06465186-efinopegdutide:v1","objectPathId":"clinicaltrials-gov-nct06465186-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06465186-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#clinicaltrials-gov-nct06465186-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#clinicaltrials-gov-nct06465186-efinopegdutide-v1"},"story":{"slug":"clinicaltrials-gov-nct06465186-efinopegdutide","version":1,"domain":"Clinical trials","dateInSource":"2026-09-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06465186","sourceIds":["ctg-observation-nct06465186-2026-09-21-8a332c7b1c3c"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06465186 at 2026-11-16T17:46:45.897Z. Its registry update date was 2026-09-21, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06465186-2026-09-21-8a332c7b1c3c"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06465186 at 2026-11-16T17:46:45.897Z. Its registry update date was 2026-09-21, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06465186-2026-09-21-8a332c7b1c3c"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06465186-2026-09-21-8a332c7b1c3c"]}],"sources":[{"id":"ctg-observation-nct06465186-2026-09-21-8a332c7b1c3c","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06465186 · retained source version 2026-09-21:8a332c7b1c3c54dee1dbf3c396b3f4763f1b00dc98be381a4cc75d4a9c16eeec","url":"https://clinicaltrials.gov/study/NCT06465186"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a8018ced81363d60f7bd8185f7030972af8b13fd9f95e3c2f9c5ec00a609228e","tierARecordSha256":"7d24e1715d28ff3713bd3e9d6ca7f9a0b84882774a47d64f127db4fe7c687ee6"},"integrity":{"algorithm":"sha256","contentSha256":"875f66b9711a1f5732adc3fd13351f20fb44e3843f1245760d906720cb07f197"}},"clinicaltrials-gov-nct06482112-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06482112-efinopegdutide:v1","objectPathId":"clinicaltrials-gov-nct06482112-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06482112-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#clinicaltrials-gov-nct06482112-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#clinicaltrials-gov-nct06482112-efinopegdutide-v1"},"story":{"slug":"clinicaltrials-gov-nct06482112-efinopegdutide","version":1,"domain":"Clinical trials","dateInSource":"2026-06-01","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06482112","sourceIds":["ctg-observation-nct06482112-2026-06-01-0d94549d811f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06482112 at 2026-11-16T17:46:45.897Z. Its registry update date was 2026-06-01, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06482112-2026-06-01-0d94549d811f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06482112 at 2026-11-16T17:46:45.897Z. Its registry update date was 2026-06-01, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06482112-2026-06-01-0d94549d811f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06482112-2026-06-01-0d94549d811f"]}],"sources":[{"id":"ctg-observation-nct06482112-2026-06-01-0d94549d811f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06482112 · retained source version 2026-06-01:0d94549d811f3d5713b582d654c3f76e86088a7e895f84c6ceaf82c144ade106","url":"https://clinicaltrials.gov/study/NCT06482112"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2150df88411a684e70440a4771cab0ed70a3dcddc97ad30521c18d39c8307f68","tierARecordSha256":"aaf58b8c893927608da529805b1b719d4389f186fa826d689f01409d3a37a74c"},"integrity":{"algorithm":"sha256","contentSha256":"94ad699d1a3d104df86195b54f2601da9ba782f6adeee8697df0430f57657f67"}},"clinicaltrials-gov-nct06701305-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06701305-efinopegdutide:v1","objectPathId":"clinicaltrials-gov-nct06701305-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06701305-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#clinicaltrials-gov-nct06701305-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#clinicaltrials-gov-nct06701305-efinopegdutide-v1"},"story":{"slug":"clinicaltrials-gov-nct06701305-efinopegdutide","version":1,"domain":"Clinical trials","dateInSource":"2025-02-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06701305","sourceIds":["ctg-observation-nct06701305-2025-02-26-a803811e856c"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06701305 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-02-26, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06701305-2025-02-26-a803811e856c"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06701305 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-02-26, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06701305-2025-02-26-a803811e856c"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06701305-2025-02-26-a803811e856c"]}],"sources":[{"id":"ctg-observation-nct06701305-2025-02-26-a803811e856c","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06701305 · retained source version 2025-02-26:a803811e856c89e8302ba4794ce74615ae5aff2d6b5191a72fc4b760a0268a6e","url":"https://clinicaltrials.gov/study/NCT06701305"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"77eaa8a6784f9f9f4860b52cd71e4e65c944b9f6077820b676454d7d52f4cb46","tierARecordSha256":"53c756aba4403b22fdaedcfb9e0146ecd20d6d494e280d183e747036defebb99"},"integrity":{"algorithm":"sha256","contentSha256":"3ce74633a6a5391dc751225a94daf8a6ff5da030a9efe4f92dc0baabff517233"}},"clinicaltrials-gov-nct06836037-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06836037-efinopegdutide:v1","objectPathId":"clinicaltrials-gov-nct06836037-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06836037-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#clinicaltrials-gov-nct06836037-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#clinicaltrials-gov-nct06836037-efinopegdutide-v1"},"story":{"slug":"clinicaltrials-gov-nct06836037-efinopegdutide","version":1,"domain":"Clinical trials","dateInSource":"2025-02-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06836037","sourceIds":["ctg-observation-nct06836037-2025-02-21-35465b738a09"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06836037 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-02-21, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06836037-2025-02-21-35465b738a09"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06836037 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-02-21, and PeptideScanner's reviewed identity mapping was efinopegdutide.","sourceIds":["ctg-observation-nct06836037-2025-02-21-35465b738a09"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06836037-2025-02-21-35465b738a09"]}],"sources":[{"id":"ctg-observation-nct06836037-2025-02-21-35465b738a09","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06836037 · retained source version 2025-02-21:35465b738a09f50fb88450937d53765213390ac337e35393d046a25587a1cae1","url":"https://clinicaltrials.gov/study/NCT06836037"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"615717e3579d741ea9efa0e7439ab5d3064ad0d3092eb6084f2e90601f508058","tierARecordSha256":"2096fede8cf40ad52041aba85ceed9dd2b0220a3e8215ef4583bfd4b28ef8fe7"},"integrity":{"algorithm":"sha256","contentSha256":"b1a4c415fac83094490e25dfa0bb8b754bff2add04f862b419eb43188f9829ed"}},"pubmed-pmid-43003104-efinopegdutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-43003104-efinopegdutide:v1","objectPathId":"pubmed-pmid-43003104-efinopegdutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-43003104-efinopegdutide/","json":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.json#pubmed-pmid-43003104-efinopegdutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efinopegdutide.md#pubmed-pmid-43003104-efinopegdutide-v1"},"story":{"slug":"pubmed-pmid-43003104-efinopegdutide","version":1,"domain":"Literature metadata","dateInSource":"2026-11-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efinopegdutide"],"peptides":[{"slug":"efinopegdutide","url":"https://peptidescanner.com/peptides/efinopegdutide/"}]},"claims":[{"id":"headline","text":"Efinopegdutide: a step towards precision in MASH therapy?","sourceIds":["pubmed-observation-pmid-43003104-2026-11-09-930645f05b94"]},{"id":"summary","text":"PubMed lists PMID 43003104 in Lancet (London, England) as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug efinopegdutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-43003104-2026-11-09-930645f05b94"]},{"id":"paragraph-1","text":"PubMed lists PMID 43003104 in Lancet (London, England) as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug efinopegdutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-43003104-2026-11-09-930645f05b94"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-43003104-2026-11-09-930645f05b94"]}],"sources":[{"id":"pubmed-observation-pmid-43003104-2026-11-09-930645f05b94","name":"PubMed","sourceClass":"A","title":"Efinopegdutide: a step towards precision in MASH therapy? · retained source version 1:2026-11-09:current:930645f05b948e3cddc7b41337a36b325a8a5a8ab4a221f26bc92c280f2f5ea9","url":"https://pubmed.ncbi.nlm.nih.gov/43003104/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b7dcfdc357a4545066da4c0a910a30abb6db6b8970e23cd01b35a5f0ffcca4c2","tierARecordSha256":"e91c14abc9747246d3d56d6d61d4e1c6e6958e23a375aa2b417059dd13c21978"},"integrity":{"algorithm":"sha256","contentSha256":"c477a4be75907769ed4b198819b15b80aa94cbd029608a47cfeb35dc7c95a3f4"}}}}
